Created date

Published on

You are here:

MS in the media - 2 December 2016

26 November - 2 December 2016

These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts

Sports Personality of the Year shortlist published

Kadeena Cox, who has MS, has been included in the shortlist for the BBC's Sports Personality of the Year award.  The cyclist and athlete is one of three Paralympians on the list

Source: BBC
Source: Daily Star

MS Trust link: Grit and determination - interview with Kadeena Cox

Vitamin D and MS risk

Danish research used blood samples taken at birth from people born after April 1981 - 521 of whom had developed MS by 2012 and 972 didn't have MS. The lower the vitamin D levels at birth, the higher the proportion who had subsequently developed MS.

Source: Medical News Today
Source: National MS Society (USA)

MS Trust link: Vitamin D

What stem cell research says about progressive MS

Researchers found that stem cells derived from the blood of people with progressive MS did not protect mice with an MS like condition or promote myelin repair.  Stem cells derived from people who didn't have MS did do this.  This is seen as suggesting something about the nature of progressive MS

Source: National MS Society (USA)

MS Trust link: A short guide to stem cell therapy

Researching diet and MS

An article looking at the potential role of diet in MS, the difficulties with planning objective studies and some of the ongoing research.

Source: Nature

MS Trust link: Diet

Emerging treatments for progressive MS

An overview of the treatments that are being studied for progressive MS and which offer hope that a drug may soon be available for this type of MS

Source: Nature

MS Trust link: Drugs in development